Context Therapeutics Inc.
Nasdaq: CNTXPharmaceutical Preparations · Entity-resolved by Clous
CIK0001842952
TickerCNTX
ExchangeNasdaq
SIC2834
StateDE
FY end12-31
Key financials
Revenue
—
—
Net IncomeFY2025-12-31
-$36.12M
-35.2% YoY
Total AssetsFY2025-12-31
$68.49M
-30.2% YoY
EquityFY2025-12-31
$60.47M
-36.5% YoY
Shares OutstandingFY2025-12-31
91.88M
—
Operating Cash FlowFY2025-12-31
-$26.39M
-81.3% YoY
Short interest & fails
Cost to borrow1.00%1.3M shares availablehard to borrow
Short-sale volume
FINRA Reg SHO · daily30.2%
short of total volume · 2026-06-18
2026-06-1830.2%
2026-06-1752.5%
2026-06-1651.7%
2026-06-1548.0%
2026-06-1221.6%
Fails-to-deliver
SEC CNS fails · semi-monthly13.85K
shares failed · 2026-05-18
2026-05-1813.85K sh$2.16
2026-05-152.01K sh$2.33
2026-05-122.98K sh$2.39
2026-04-162K sh$2.51
2026-03-31240 sh$2.45
Short volume (FINRA Reg SHO) · fails-to-deliver (SEC) · borrow fee (broker securities-lending feed) — via the Clous API.
AI business summary — latest 10-K
Summary
The filing text is unavailable, so no specific information can be extracted.
What it means
Cannot assess significance without the filing content.
What to watch
Monitor for the release of the complete Form 10-K to analyze details.
Generated from public filings · not investment advice
| Concept | FY2022-12-31 | FY2023-12-31 | FY2024-12-31 | FY2025-12-31 | YoY | % rev |
|---|---|---|---|---|---|---|
| Net Income | -$14.84M | -$23.96M | -$26.73M | -$36.12M | -35.2% | — |
| Total Assets | $37.97M | $16.06M | $98.13M | $68.49M | -30.2% | — |
| Equity | $34.76M | $11.87M | $95.27M | $60.47M | -36.5% | — |
| Operating Cash Flow | -$13.55M | -$21.05M | -$14.56M | -$26.39M | -81.3% | — |
| Shares Outstanding | — | — | — | 91.88M | — | — |
Get this entity — and 970.89K+ others — programmatically.
One clean JSON shape, resolved IDs, MCP-native. Query the same data behind this page.
GET /v1/entities?cik=0001842952